1. Home
  2. SPRY vs SPFI Comparison

SPRY vs SPFI Comparison

Compare SPRY & SPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$5.64

Market Cap

788.5M

Sector

Health Care

ML Signal

HOLD

Logo South Plains Financial Inc.

SPFI

South Plains Financial Inc.

HOLD

Current Price

$44.42

Market Cap

794.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRY
SPFI
Founded
2015
1941
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
788.5M
794.2M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
SPRY
SPFI
Price
$5.64
$44.42
Analyst Decision
Strong Buy
Buy
Analyst Count
1
3
Target Price
$40.00
$46.00
AVG Volume (30 Days)
2.0M
150.0K
Earning Date
05-11-2026
04-28-2026
Dividend Yield
N/A
1.68%
EPS Growth
N/A
17.81
EPS
N/A
0.85
Revenue
$84,278,000.00
N/A
Revenue This Year
$87.40
$22.65
Revenue Next Year
$81.64
$9.40
P/E Ratio
N/A
$52.51
Revenue Growth
N/A
N/A
52 Week Low
$5.76
$35.34
52 Week High
$18.50
$46.94

Technical Indicators

Market Signals
Indicator
SPRY
SPFI
Relative Strength Index (RSI) 23.59 58.76
Support Level N/A $39.06
Resistance Level $8.61 $46.94
Average True Range (ATR) 0.44 1.34
MACD -0.18 0.09
Stochastic Oscillator 2.54 58.19

Price Performance

Historical Comparison
SPRY
SPFI

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

About SPFI South Plains Financial Inc.

South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking. The majority of the company's revenues is derived from interest income and other sources, including loans, securities and derivatives.

Share on Social Networks: